Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

MRKR

Marker Therapeutics Inc

May 22 • 04:00PM ET

1.40

-0.03 -2.10 %

Healthcare • Biotechnology • USA • Nano • NASD

Peers: INAB CNTX XLO PGEN IMNN

| Held by: VTI VXF

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-0.67	Insider Own	19.03%	Shs Outstand	16.67M	Perf Week	-1.41%
Market Cap	23.34M	Forward P/E	-	EPS next Y	-1.01	Insider Trans	0.00%	Shs Float	13.50M	Perf Month	-3.45%
Enterprise Value	7.70M	PEG	-	EPS next Q	-0.16	Inst Own	12.33%	Short Float	1.12%	Perf Quarter	-4.76%
Income	-10.90M	P/S	7.29	EPS this Y	-21.94%	Inst Trans	0.07%	Short Ratio	1.31	Perf Half Y	28.44%
Sales	3.20M	P/B	1.69	EPS next Y	-5.19%	ROA	-63.30%	Short Interest	0.15M	Perf YTD	-6.04%
Book/sh	0.83	P/C	1.49	EPS next 5Y	-	ROE	-77.04%	52W High	4.07 -65.60%	Perf Year	23.89%
Cash/sh	0.94	P/FCF	-	EPS past 3/5Y	39.48% 33.49%	ROIC	-78.98%	52W Low	0.81 72.86%	Perf 3Y	7.69%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	0.31% 50.02%	Gross Margin	-	Volatility	3.86% 5.27%	Perf 5Y	-94.95%
Dividend TTM	-	EV/Sales	2.41	EPS Y/Y TTM	49.21%	Oper. Margin	-386.37%	ATR (14)	0.08	Perf 10Y	-97.95%
Dividend Ex-Date	-	Quick Ratio	4.79	Sales Y/Y TTM	-43.86%	Profit Margin	-340.78%	RSI (14)	44.11	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	4.79	EPS Q/Q	58.88%	SMA20	-3.08%	Beta	1.43	Target Price	7.87
Payout	-	Debt/Eq	0.00	Sales Q/Q	-100.00%	SMA50	-3.15%	Rel Volume	0.55	Prev Close	1.43
Employees	5	LT Debt/Eq	0.00	Earnings	Mar 18 AMC	SMA200	6.37%	Avg Volume	115.31K	Price	1.40
IPO	Jan 05, 1998	Option/Short	No / Yes	EPS/Sales Surpr.	48.95% 61.43%	Trades		Volume	63,235	Change	-2.10%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)